肝动脉化疗栓塞联合无水乙醇量化治疗复发性肝癌  

Clinical efficacy of TACE in combination with PEI for treatment of recurrence liver cancer

作　　者：韦忠恒[1] 钟秋红[1] 韦建宝[1] 陆建勋[1] 浦涧[1] 黄斌[1] 崔翠新[1] 

机构地区：[1]右江民族医学院附属医院,广西百色533000

出　　处：《右江民族医学院学报》2006年第5期729-731,共3页Journal of Youjiang Medical University for Nationalities

基　　金：广西百色市科技局基金资助项目[(2004)16]

摘　　要：目的探讨肝动脉插管化疗栓塞(TACE)联合经皮肝穿刺瘤内注射无水乙醇(PEI)治疗复发性肝癌(肝癌)的临床效果。方法回顾性分析经TACE和PEI治疗的46例手术后肝癌病例及随访资料,分析其疗效及生存率。结果46例中完全缓解(CR)11例,部分缓解(PR)31例,无变化(NR)2例,进展(PD)2例,总有效率为91.30%。1、2、3、4、5年生存率为84.78%、73.91%、56.52%、36.95%、19.65%。结论TACE联合PEI治疗肝癌可提高患者的生存率。Objective To investigate the clinical efficacy of transcatheter hepatic arterial chemoemblization （TACE） in combination with percutaneous ethanol injection therapy （PEI） for the treatment of recurrence liver cancer. Methods The curative results and survival rate were retrospectively analyzed in 46 patients with liver cancer which were treated with TACE in combination with PEI after surgery. Results 46 patients treated with TACE in combination with PEI, of 11 cases were found with complete relid, of 31 cases with partial relid, of 2 cases with minor rellef. A total effective rate of 91.30% was found. 1- ,2- ,3- ,4- and 5- year survival rates were 84. 78 %, 73.91%, 56.52 %, 36.95 % and 19.65 %, respectively. effective therapy for the treatment of liver cancer and can increase the patients＇ TACE incombinaion with PEI is an survival rate.

关 键 词：肝肿瘤 外科手术 复发 肝动脉 插管法 抗肿瘤联合化疗方案 栓塞 无水酒精 

分 类 号：R735.7[医药卫生—肿瘤]